About Starr Life Sciences
Starr Life Sciences is a Healthcare company based in Oakmont (United States) founded in 2004. It operates as a noninvasive vital signs monitoring systems specifically designed for small laboratory animals. Starr Life Sciences has raised $2.31 million across 3 funding rounds. Starr Life Sciences offers products and services including MouseOx® Plus, Telemetry System, and Activity Monitoring. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is Starr Life Sciences Corp. Its competitors include GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics and 5 more; 9 of its 10 listed competitors have raised funding.
Company details
STARR Life Sciences Corp. manufactures the MouseOx Plus pulse oximeter, the worlds first and only patented noninvasive vital signs monitor specifically designed for mice, rats, and other small laboratory animals. The MouseOx and The MouseOx Plus are being used by researchers and veterinarians from universities, pharmaceutical companies, and CROs for the measurement of heart rate, arterial oxygen saturation (SpO2), breath rate, and temperature. In 2013, STARR Life Sciences acquired the VitalView softwareE-Mitter telemetry product line from Philips Respironics, Inc. The companys product portfolio includes Telemetry systems (for monitoring temperature, gross motor activity and heart rate), mouse and rat running wheels (for monitoring voluntary activity 24x7), Animal Actical (for measuring energy expenditure and step count) and infrared cage top motion sensor (for monitoring gross motor activity 247).
- Headquarters Oakmont, United States
- SectorsHealthcare
- Website starrlifesciences.com
- Social LinkedIn
- Legal Name Starr Life Sciences Corp.
- Total Equity Funding$2.31M (USD)
in 3 rounds
- Latest Funding Round$519.86K (USD), Seed
Jul 2011
Products & Services of Starr Life Sciences
Starr Life Sciences offers a comprehensive portfolio of products and services, including MouseOx® Plus, Telemetry System, and Activity Monitoring.
Monitors heart rate and oxygen saturation in small animals for research.
Enables continuous monitoring of temperature and activity in mice and rats.
Detects gross motor activity using infrared systems for animal studies.
Funding Insights of Starr Life Sciences
Starr Life Sciences has successfully raised a total of $2.31M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $519.86 thousand completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.31M
- Total Rounds 3
- Last Round Seed — $519,862
- First Round $1.42M
(Jan 2007)
All 3 funding rounds of Starr Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2011 | $519,862 | Seed | – | – | – |
| Jun 2009 | $1.79M | Seed | – | – | – |
| Jan 2007 | $1.42M | Debt – Convertible | – | – | – |
Timeline of Starr Life Sciences
3 dated milestones of Starr Life Sciences across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Starr Life Sciences is founded.
- Funding First funding round of $1.4M.
- Funding Latest funding round, Seed, of $520K.
Competitors of Starr Life Sciences
Starr Life Sciences has 10 listed competitors in our database, 9 of them funded. They include GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| lifeminetx.com | 2016 | Cambridge, United States | $300.07M | 85 | Developer of novel drugs from fungi via genome mining and recombinant overexpression |
Detailed competitors of Starr Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Starr Life Sciences
The website of Starr Life Sciences (starrlifesciences.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▲ 16.1% vs previous month
Websites whose visitors overlap most with Starr Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| kentscientific.com | 100% | – | #1,335,594 | View details | |
| novasenta.com | 42% | 2.4K | #6,002,810 | View details | |
| plexision.com | 41% | 3.2K | #5,846,553 | View details | |
| ecmtherapeutics.com | 41% | 2.6K | #6,640,901 | View details | |
| bluespherebio.com | 40% | 2.5K | #6,529,430 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Starr Life Sciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Starr Life Sciences (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Starr Life Sciences
Starr Life Sciences was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Starr Life Sciences is headquartered in Oakmont, United States. It is registered at Oakmont, Pennsylvania, United States.
Starr Life Sciences is a funded company, having raised a total of $2.31M across 3 funding rounds to date. The company's 1st funding round was a Debt – Convertible of $1.42M, raised on Jan 2007.
STARR Life Sciences Corp. manufactures the MouseOx Plus pulse oximeter, the worlds first and only patented noninvasive vital signs monitor specifically designed for mice, rats, and other small laboratory animals. The MouseOx and The MouseOx Plus are being used by researchers and veterinarians from universities, pharmaceutical companies, and CROs for the measurement of heart rate, arterial oxygen saturation (SpO2), breath rate, and temperature. In 2013, STARR Life Sciences acquired the VitalView softwareE-Mitter telemetry product line from Philips Respironics, Inc. The companys product portfolio includes Telemetry systems (for monitoring temperature, gross motor activity and heart rate), mouse and rat running wheels (for monitoring voluntary activity 24x7), Animal Actical (for measuring energy expenditure and step count) and infrared cage top motion sensor (for monitoring gross motor activity 247).
Starr Life Sciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Starr Life Sciences offers MouseOx® Plus, Telemetry System, and Activity Monitoring.
Starr Life Sciences operates through Starr Life Sciences Corp..